Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Expression and activity of urokinase and its receptor in endothelial cells exposed to asbestos.

Authors
Treadwell-MD; Fava-RA; Hunt-JA; Krieser-RJ; Barchowsky-A
Source
Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire and Department of Medicine, Veterans Hospital, White River Junction, Vermont 1996 Jan; :1-28
Link
NIOSHTIC No.
00238185
Abstract
Endothelial cells were exposed to chrysotile (12001295), crocidolite (12001284), or refractory-ceramic-fiber-1 (RCF-1) in an effort to determine whether asbestos induced endothelial cell activation is associated with altered proteolysis and expression of urokinase-like- plasminogen-activator (uPA) and urokinase-like-plasminogen-activator- receptor (uPAR). Second or third passage porcine aortic endothelial cells grown to confluence were incubated with the fibers for up to 24 hours. In-situ zymography for uPA activity in exposed cultures demonstrated that these fibers produce localized increases in proteolysis. Within 8 hours, exposure to chrysotile or crocidolite increased uPA expression. The increases in proteolysis correlate well with increases in steady state uPA mRNA levels and with increased levels of uPAR protein. In contrast, rRCF-1 has a lower fibrogenic potential than asbestos and it failed to elicit endothelial cell activation or affect uPA/uPAR. The authors suggest that asbestos fibers directly activate vascular endothelial cells to express proteins that facilitate tissue remodeling.
Keywords
NIOSH-Grant; Pulmonary-system-disorders; Lung-irritants; Asbestos-fibers; Fibrous-dusts; Cytotoxic-effects; Cell-damage; Mammalian-cells
Contact
Pharmacology and Toxicology Dartmouth Medical School Remsen 7650 Hanover, NH 03755-3835
CAS No.
12001-29-5; 12001-28-4; 1332-21-4
Publication Date
19960101
Document Type
Final Grant Report
Funding Amount
76183
Funding Type
Grant
Fiscal Year
1996
NTIS Accession No.
PB97-206304
NTIS Price
A03
Identifying No.
Grant-Number-R03-OH-003267
NIOSH Division
OEP
Priority Area
Pulmonary-system-disorders
Source Name
Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire and Department of Medicine, Veterans Hospital, White River Junction, Vermont
State
NH; VT
Performing Organization
Dartmouth College, Hanover, New Hampshire
TOP